Prosus’s red report card for underperformers Byju’s, PharmEasy

This is the third time Prosus has marked down its valuation of the beleaguered edtech firm within a year.

30 November, 20231 min
0
Prosus’s red report card for underperformers Byju’s, PharmEasy

You may also like

Business
Story image

Debt, dividends, divestment: how solid is Sitharaman’s budget math?

Fiscal discipline holds on paper, but the number is propped up by higher borrowing and revenue sources that are far from stable.

Business
Story image

Maruti’s comfort zone is now its biggest risk

A revival in small-car sales has restored the automaker’s advantage, but tougher fuel-efficiency norms threaten to turn its greatest strength into a liability.

Business
Story image

Yes Bank’s succession problem is a board problem

As Prashant Kumar’s term runs out, boardroom fault lines have left the lender with no clarity on its next CEO—spooking investors and drawing the RBI’s ire.